Mental Health

ClinicalAugust 1, 2026

Baroque Music Therapy Shows Potential to Reduce Anxiety in Major Depressive Disorder Patients

A study is investigating the effects of Baroque music on reducing anxiety in patients with major depressive disorder.

ClinicalJuly 23, 2026

Efficacy of COPE-A for PTSD and SUD in Young People Demonstrated in RCT

The COPE-A treatment showed significantly greater reductions in PTSD symptom severity compared to supportive counseling at 4 months, with effects maintained at 12 months.

StrategyJuly 21, 2026

FDA Grants Abbreviated Approval for Bupropion Hydrochloride by Graviti Pharms

The FDA has granted abbreviated approval for Bupropion Hydrochloride under application ANDA211020 submitted by Graviti Pharms.

ClinicalJuly 20, 2026

Study on Mental Health Outcomes Post-Pregnancy Loss in Denmark

A study is underway to evaluate the mental health impacts of participating in the COPL cohort versus standard care after pregnancy loss.

ClinicalJuly 17, 2026

Study on Exercise Impact on Mental Health in Psychiatric Inpatients Initiated by Johns Hopkins

A placebo-controlled study will assess the effects of exercise on neuropsychiatric symptoms in psychiatric inpatients.

ClinicalJuly 15, 2026

Study on Mental Health Services for Older Cancer Patients Launched

A new study is assessing the effectiveness of the Open Door for Cancer approach in connecting older cancer patients with mental health services.

CompetitiveJuly 14, 2026

FDA Supports Development of Psychedelic Drugs for Mental Health

The FDA is actively supporting the development of psychedelic drugs aimed at treating serious mental health conditions.

ClinicalJuly 11, 2026

NIMH Study on Adolescent Depression Aims to Enhance Treatment Understanding

The NIMH is conducting a study to explore causes and treatments for depression in adolescents aged 11-17, comparing those with and without mental health diagnoses.

ClinicalJuly 9, 2026

Adapting STAIR-NT for Polysubstance Users in Opioid Treatment Programs

The STAIR-NT intervention was adapted for patients using stimulants and opioids, showing promise in meeting treatment needs.

CompetitiveJuly 7, 2026

Evaluation of Gamified Mobile App for Depression Shows Promise in Reducing Symptoms

A study is evaluating a gamified mobile app aimed at reducing symptoms of depression through attention bias modification training.

ClinicalJuly 5, 2026

Neurovalens Initiates VeNS Trial for Adolescent Anxiety Treatment

Neurovalens Ltd. is conducting a randomized trial to assess the efficacy of Electrical Vestibular Stimulation for Generalized Anxiety Disorder in adolescents.

ClinicalJune 25, 2026

Psilocybin-Assisted Psychotherapy Trial for Cancer Survivors Launched

A clinical trial is underway to evaluate the feasibility and safety of psilocybin-assisted psychotherapy for cancer survivors experiencing depression and/or anxiety.

ClinicalJune 18, 2026

ACT vs CBT Trial for Psychological Distress in HIV/AIDS Patients

A randomized controlled trial is underway comparing Acceptance and Commitment Therapy and Cognitive Behavioral Therapy in HIV/AIDS patients.

ClinicalJune 11, 2026

Trial Comparing Behavioral Activation to Relapse Prevention for Veterans with AUD and PTSD

This clinical trial aims to adapt and evaluate Behavioral Activation for veterans with co-occurring AUD and PTSD against Relapse Prevention.

ClinicalJune 11, 2026

Pilot Trial of Digitally Enhanced Stepped-Care for Depression in Primary Care Initiated

A pilot trial is evaluating a digitally enhanced stepped-care approach for treating depression in primary care settings.

Companies

Assets

Recent signals(15)